Every earnings call for MOL — management tone, guidance, KPIs and promise tracking, quarter by quarter.
MOL · 5 transcripts · Chemicals · latest Q4 FY26Meghmani Organics Limited has 5 earnings calls on record here, a Chemicals company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
FY26 Consolidated Revenue ₹2,174 cr (+5% YoY); FY26 Consolidated EBITDA ₹176 cr (+24% YoY); FY26 Consolidated EBITDA Margin 8.1%. FY26 standalone revenue grew 4% YoY to INR2,091 crores.
Read full transcript & analysisStandalone Revenue ₹485 cr; Standalone EBITDA ₹51 cr; Standalone EBITDA Margin 10.6%. Standalone revenue stood at ₹485 crores, with PAT at ₹22 crores.
Read full transcript & analysisStandalone Revenue ₹558 cr (+5% YoY); Standalone EBITDA ₹70 cr (+71% YoY); Standalone PAT ₹43 cr. Standalone Revenue up 5% YoY to INR 558 crores.
Read full transcript & analysisStandalone Revenue ₹593 cr (+44% YoY); Standalone EBITDA ₹81 cr (+478% YoY); Standalone PAT ₹40 cr. Standalone revenue grew 44% YoY to ₹593 crores.
Read full transcript & analysisFY25 Revenue ₹2,000 cr (+30% YoY); FY25 EBITDA ₹180 cr (+1795% YoY); FY25 PAT ₹66 cr. Q4 FY25 standalone revenue up 26% YoY to ~INR 500 crores.
Read full transcript & analysis